The fd phage and a peptide derived from its p8 coat protein interact with the HIV-1 Tat-NLS and inhibit its biological functions

被引:13
|
作者
Krichevsky, A
Rusnati, M
Bugatti, A
Waigmann, E
Shohat, S
Loyter, A
机构
[1] Hebrew Univ Jerusalem, Dept Biol Chem, Alexander Silberman Inst Life Sci, IL-91904 Jerusalem, Israel
[2] Univ Brescia, Sch Med, Dept Biomed Sci & Biotechnol, I-25123 Brescia, Italy
[3] Vienna Bioctr, Univ Dept, Max F Perutz Labs, Inst Med Biochem, A-1030 Vienna, Austria
关键词
HIV-1; Tat; Fd bacteriophage; inhibitory peptide; nuclear-import;
D O I
10.1016/j.antiviral.2005.01.004
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Filamentous fd bacteriophages are used to construct phage-display peptide libraries, which have been instrumental in selecting peptides that interact with specific domains within target molecules. Here we demonstrate that the Id bacteriophage itself, as well as NTP8 - a synthetic peptide derived from it and bearing amino acids 1-20 of the phage p8 protein - interact with the nuclear localization signal (NLS) of the HIV-1 Tat protein. Accordingly. fd bacteriophage and the NTP8 peptide inhibit binding mediated by the Tat-NLS to the nuclear-import receptor importin beta and Tat-NLS-mediated translocation into cell nuclei. The NTP8 peptide, at 100 mu M concentration, also caused about 50% inhibition of HIV-1 propagation in cultured cells. The fd bacteriophage prevents heparan sulfate proteoglycans-mediated uptake of extracellular Tat by target cells and consequently transactivation of a chloramphenicol acetyltransferase (CAT) reporter gene. A BSA-NTP8 conjugate inhibits Tat-NLS-mediated binding to heparin immobilized on a BIAcore surface. BLAST analysis of the NTP8 amino-acid sequence revealed similarity to sequences in several human proteins, including ADA2 and CD53. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:67 / 78
页数:12
相关论文
共 13 条
  • [1] Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity
    Ott, M
    Schnölzer, M
    Garnica, J
    Fischle, W
    Emiliani, S
    Rackwitz, HR
    Verdin, E
    CURRENT BIOLOGY, 1999, 9 (24) : 1489 - 1492
  • [2] Cyclic peptide inhibitors of HIV-1 integrase derived from the LEDGF/p75 protein
    Hayouka, Zvi
    Hurevich, Mattan
    Levin, Aviad
    Benyamini, Hadar
    Iosub, Anat
    Maes, Michal
    Shalev, Deborah E.
    Loyter, Abraham
    Gilon, Chaim
    Friedler, Assaf
    BIOORGANIC & MEDICINAL CHEMISTRY, 2010, 18 (23) : 8388 - 8395
  • [3] HIV-1 Tat protein and its inhibitor Ro 24-7429 inhibit lymphocyte proliferation and induce apoptosis in peripheral blood mononuclear cells from healthy donors
    Patki, AH
    Lederman, MM
    CELLULAR IMMUNOLOGY, 1996, 169 (01) : 40 - 46
  • [4] The cationic cell-penetrating peptide CppTAT derived from the HIV-1 protein TAT is rapidly transported into living fibroblasts:: Optical, biophysical, and metabolic evidence
    Ziegler, A
    Nervi, P
    Dürrenberger, M
    Seelig, J
    BIOCHEMISTRY, 2005, 44 (01) : 138 - 148
  • [5] Backbone cyclic proteinomimetics derived from the arginine-rich domain of HIV-1 Tat and Rev proteins: One sequence, two conformations, two biological functions
    Friedler, A
    Luedtke, N
    Friedler, D
    Loyter, A
    Tor, Y
    Gilon, C
    PEPTIDES FOR THE NEW MILLENNIUM, 2000, : 28 - 29
  • [6] Aminoglycoside antibiotics, neamine and its derivatives as potent inhibitors for the RNA-protein interactions derived from HIV-1 activators
    Hamasaki, K
    Ueno, A
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (04) : 591 - 594
  • [7] NMR structure of the (52-96) C-terminal domain of the HIV-1 regulatory protein Vpr:: Molecular insights into its biological functions
    Schüler, W
    Wecker, K
    de Rocquigny, H
    Baudat, Y
    Sire, J
    Roques, BP
    JOURNAL OF MOLECULAR BIOLOGY, 1999, 285 (05) : 2105 - 2117
  • [8] Peptide Derived from HIV-1 TAT Protein Destabilizes a Monolayer of Endothelial Cells in an in Vitro Model of the Blood-Brain Barrier and Allows Permeation of High Molecular Weight Proteins
    Cooper, Itzik
    Sasson, Keren
    Teichberg, Vivian I.
    Schnaider-Beeri, Michal
    Fridkin, Mati
    Shechter, Yoram
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (53) : 44676 - 44683
  • [9] UV and X-ray structural studies of a 101-residue long Tat protein from a HIV-1 primary isolate and of its mutated, detoxified, vaccine candidate
    Foucault, Marine
    Mayol, Katia
    Receveur-Brechot, Veronique
    Bussat, Marie-Claire
    Klinguer-Hamour, Christine
    Verrier, Bernard
    Beck, Alain
    Haser, Richard
    Gouet, Patrice
    Guillon, Christophe
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2010, 78 (06) : 1441 - 1456
  • [10] HIV-1 Tat protein exits from cells via a leaderless secretory pathway and binds to extracellular matrix-associated heparan sulfate proteoglycans through its basic region
    Chang, HC
    Samaniego, F
    Nair, BC
    Buonaguro, L
    Ensoli, B
    AIDS, 1997, 11 (12) : 1421 - 1431